Is tongue atrophy reversible in anti-MuSK myasthenia gravis? Six-year observation.
Takahashi
Hirokatsu
H
Kawaguchi
Naoki
N
Ito
Shoichi
S
Nemoto
Yuko
Y
Hattori
Takamichi
T
Kuwabara
Satoshi
S
D001284:Atrophy / Q000209:etiology / Q000473:pathology; D001323:Autoantibodies / Q000276:immunology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications* / Q000235:genetics* / Q000276:immunology; D010375:Pedigree; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics*; D011950:Receptors, Cholinergic / Q000235:genetics* / Q000276:immunology; D013997:Time Factors; D014059:Tongue / Q000503:physiopathology*
D001323:Autoantibodies; D011950:Receptors, Cholinergic; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases